Fortitude Family Office’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261 Buy
+212
New +$211 ﹤0.01% 2079
2026
Q1
Sell
-1,837
Closed -$2.85K 2013
2025
Q4
$2.85K Buy
+1,837
New +$2.93K ﹤0.01% 1031
2025
Q3
Sell
-693
Closed -$1.51K 2087
2025
Q2
$1.51K Buy
+693
New +$1.68K ﹤0.01% 1329

Other funds holding MXCT

Fortitude Family Office's MXCT Position: Q2 2026 in Review

Fortitude Family Office opened a new position in MaxCyte (MXCT) in Q2 2026: 212 shares worth $261. The stake represents ﹤0.01% of the portfolio and ranks #2079 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in MXCT as recently as Q4 2025.

Fortitude Family Office first reported a position in MXCT in Q2 2025 and has held it in 3 quarters since. The position peaked at $2.85K in Q4 2025. 19 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Fortitude Family Office held 212 shares of MaxCyte worth $261 as of Q2 2026.
  • MaxCyte was a new Fortitude Family Office position in Q2 2026.
  • MaxCyte made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2079 holding.
  • Fortitude Family Office first reported a position in MaxCyte in Q2 2025 and has held it in 3 quarters since.
  • Fortitude Family Office's MaxCyte position peaked at $2.85K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.